Shares of Dr Reddy’s Laboratories turned volatile falling 30 per cent to Rs 1,873 apiece, also its 52-week low on the National Stock Exchange (NSE), after media reported Jefferies, in its research note, said that the Form 483 issued by US Food and Drug Administration (US FDA) to drug firm’s Bachupally plant contains four repeat observations out of the total 11 observations.
At 11:14 am; Dr Reddy’s Laboratories was trading 7 per cent lower at Rs 2,474, recovering 32 per cent from its early morning low on the back of heavy volumes on the NSE.